Total cases +<unk>  confirmed cases and deaths Cases Deaths WHO total as of Jan 2020 2519 866 34.3% Reported confirmed cases per country Saudi Arabia 1029 452 44% South Korea 184 38 20% 74 10 14% Jordan 19 6 32% Qatar 10 4 40% Oman 5 3 60% Iran 5 2 40% United Kingdom 4 3 75% Germany 3 1 33% Kuwait 3 1 33% Tunisia 3 1 33% Algeria 2 1 50% France 2 1 50% Spain 2 0 0% Netherlands 2 0 0% Philippines 2 0 0% United States 2 0 0% Greece 1 1 100% Malaysia 2 1 50% Turkey 1 1 100% Yemen 1 1 100% Austria 1 0 0% Egypt 1 0 0% Italy 1 0 0% Lebanon 1 0 0% Thailand 1 0 0% Reported total 1360 527 39%<unk>  has had a relatively low population-wide reproduction number in previous outbreaks, but such outbreaks have occurred due to superspreading events. Total laboratory-confirmed cases of<unk>  world-wide per year have been as follows: 2012 2013 2014 2015 2016 2017 2018 2019 14 100 381 492 249 250 147 212 Saudi Arabia<unk>  was also implicated in an outbreak in April 2014 in Saudi Arabia, where<unk>  has infected 688 people and 282<unk> -related deaths have been reported since 2012. In response to newly reported cases and deaths, and the resignation of four doctors at Jeddah's King Fahd Hospital who refused to treat<unk>  patients for fear of infection, the government removed the Minister of Health and set up three<unk>  treatment centers. Eighteen more cases were reported in early May. In June 2014, Saudi Arabia announced 113 previously unreported cases of<unk> , revising the death toll to 282. A hospital-related outbreak in Riyadh in the summer of 2015 increased fears of an epidemic occurring during the annual Hajj pilgrimage that was to begin in late September. After a period of few cases, cases began increasing in the middle of the summer. The CDC placed the travel health alert to level 2, which calls for taking enhanced precautions. In May 2019, 14 cases of<unk>  were reported to the World Health Organisation (WHO) by Saudi authorities, of which five were fatal. All those who died had comorbidities and other relatively serious health problems ranging from only diabetes mellitus in one person (aged 35) to complicated combinations of diabetes mellitus, hypertension and ischemic heart disease in two (65 and 80 years old) and diabetes mellitus, hypertension and nephropathy in another one who was 73 years old. Another patient who died and was 64 years old, had diabetes mellitus and hypertension. All those who died were males and three of them were reported to have had contact with, and exposure to, camels. Among the nine persons who survived were two females who were believed to have had contact with a person infected with<unk> , one being a 23-year-old healthcare worker. Of the total 14 cases, four were females and 10 were males. All females survived. Reports of fatal cases were from Riyadh, Jeddah, Madinah and Najran. WHO did not recommend screening of travelers upon arrival or traveling restrictions. United States On 2 May 2014, the Centers for Disease Control and Prevention (CDC) confirmed the first diagnosis of<unk>  in the United States at Community Hospital in Munster, Indiana. The man diagnosed was a health care worker who had been in Saudi Arabia a week earlier, and was reported to be in good condition. A second patient who also traveled from Saudi Arabia was reported in Orlando, Florida on 12 May 2014. Netherlands On 14 May 2014, officials in the Netherlands reported the first case had appeared. South Korea 2015<unk>  outbreak in South Korea In May 2015, the first case in South Korea was confirmed in a man who had visited Saudi Arabia, United Arab Emirates and Bahrain. Another man from South Korea, who was travelling to China, was diagnosed as the first case in China. So far, no Chinese citizen has been found infected. As of 27 June 2015, 19 people in South Korea have died from this outbreak, with 184 confirmed cases of infection. There have been at least 6508 quarantined. In 2018 a case was found in South Korea; the patient had recently returned from Kuwait (via Dubai). One study found that severe cases of illness had higher viral loads than milder cases, and that concentrations peaked in the second week of illness. Philippines In April 2014,<unk>  emerged in the Philippines with a suspected case of a home-bound Overseas Filipino Worker (OFW). Several suspected cases involving individuals who were on the same flight as the initial suspected case are being tracked but are believed to have dispersed throughout the country. Another suspected<unk> -involved death in Sultan Kudarat province caused the Department of Health (DOH) to put out an alert. On 6 July 2015 the DOH confirmed the second case of<unk>  in the Philippines. A 36-year-old male foreigner from the Middle East was tested positive. United Kingdom On 27 July 2015, the accident and emergency department at Manchester Royal Infirmary closed after two patients were treated for suspected<unk>  infection. The facility was reopened later that evening, and it was later confirmed by Public Health England that the two patients had tested negative for the disease. Kenya In January 2016, a larger outbreak of<unk>  among camels in Kenya was reported. By 5 February 2016 more than 500 camels had died of the disease. On 12 February 2016, the disease was reported to be<unk> . No human cases were identified, although one study found antibodies in healthy humans in Kenya. Comparisons Saudi Arabia outbreak South Korea outbreak Geographical location Middle East (Asia) Far East (Asia) City/province Riyadh, Jeddah Seoul, Daejeon, Gyeonggi province Period 11 April – 9 June 2014 4 May – 15 June 2015 Overall case number 402 150 Health-care personnel (%) 27% 17% Main transmission routes Health-care center associated Health-care center associated Previous<unk>  case before outbreak Yes No Types of secondary exposure who were not health-care personnel Admission to health-care facility 34% 30% Emergency department 8% 49% Visit to patient at health-care facility 17% 29% Annual outpatient department visit (per individual) 4.5 14.6 Annual number of hospital admission (per 100 individuals) 10.5 16.1 The table above provides a comparison between the 2014 Saudi Arabia outbreak and the South Korean outbreak in 2015 of the Middle East Respiratory Syndrome Coronavirus <unk> -CoV) infection.
MERS
BHIE
BIRCH
NOMESCO
CAPOX
DRACO
MedChi
SCAPER